FR2421871A1 - Nouveaux derives d'amines et amidines de glycerols et propanediols et medicament les contenant - Google Patents
Nouveaux derives d'amines et amidines de glycerols et propanediols et medicament les contenantInfo
- Publication number
- FR2421871A1 FR2421871A1 FR7824017A FR7824017A FR2421871A1 FR 2421871 A1 FR2421871 A1 FR 2421871A1 FR 7824017 A FR7824017 A FR 7824017A FR 7824017 A FR7824017 A FR 7824017A FR 2421871 A1 FR2421871 A1 FR 2421871A1
- Authority
- FR
- France
- Prior art keywords
- propanediols
- glycerols
- amidines
- amines
- new derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
- C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention a trait au domaine de la chimie médicale. Elle concerne de nouveaux dérivés d'amines de di-O-(n-al-kyle ou n-alcényle supérieur)-glycérols et -propanediols et leurs sels d'addition d'acides acceptables du point de vue pharmaceutique On apprécie particulièrement le 1,3-di-O-(n-hexadécyl)-2-O-(3-aminopropyl)-glycérol et ses sels d'addition d'acides acceptables du point de vue pharmaceutique. Les composés de l'invention sont doués d'activité antivirale.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/825,535 US4166132A (en) | 1977-08-18 | 1977-08-18 | Antiviral amine derivatives of glycerol and propanediols |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2421871A1 true FR2421871A1 (fr) | 1979-11-02 |
FR2421871B1 FR2421871B1 (fr) | 1982-07-02 |
Family
ID=25244254
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7824017A Granted FR2421871A1 (fr) | 1977-08-18 | 1978-08-17 | Nouveaux derives d'amines et amidines de glycerols et propanediols et medicament les contenant |
FR7905721A Granted FR2414038A1 (fr) | 1977-08-18 | 1979-03-06 | Nouveaux derives d'amidines de glycerols et propanediols et medicament les contenant |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7905721A Granted FR2414038A1 (fr) | 1977-08-18 | 1979-03-06 | Nouveaux derives d'amidines de glycerols et propanediols et medicament les contenant |
Country Status (35)
Country | Link |
---|---|
US (1) | US4166132A (fr) |
JP (3) | JPS5829939B2 (fr) |
AR (2) | AR219543A1 (fr) |
AT (1) | AT363922B (fr) |
AU (1) | AU503079B1 (fr) |
BE (1) | BE869793A (fr) |
CA (1) | CA1102354A (fr) |
CH (1) | CH634544A5 (fr) |
CS (1) | CS208155B2 (fr) |
DD (2) | DD143902A5 (fr) |
DE (3) | DE2835369C2 (fr) |
DK (1) | DK149022C (fr) |
EG (1) | EG13438A (fr) |
ES (3) | ES472659A1 (fr) |
FI (1) | FI67687C (fr) |
FR (2) | FR2421871A1 (fr) |
GB (1) | GB2005248B (fr) |
GR (1) | GR73154B (fr) |
HU (2) | HU177884B (fr) |
IE (1) | IE47151B1 (fr) |
IL (1) | IL55370A (fr) |
IN (1) | IN148386B (fr) |
IT (1) | IT1098280B (fr) |
LU (1) | LU80114A1 (fr) |
MX (1) | MX6091E (fr) |
NL (1) | NL176670C (fr) |
NO (3) | NO147300C (fr) |
NZ (1) | NZ188174A (fr) |
PH (4) | PH16469A (fr) |
PL (3) | PL115777B1 (fr) |
PT (1) | PT68426A (fr) |
SE (3) | SE447823B (fr) |
SU (3) | SU893128A3 (fr) |
YU (3) | YU41115B (fr) |
ZA (1) | ZA783855B (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4173641A (en) * | 1978-05-15 | 1979-11-06 | Pfizer Inc. | Di-O-n-alkyl glycerol derivatives as immune stimulants |
US4312877A (en) * | 1979-07-09 | 1982-01-26 | Pfizer Inc. | 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof |
YU41932B (en) * | 1979-07-09 | 1988-02-29 | Pfizer | Process for obtaining substituted piperazines and piperidi |
US4255426A (en) * | 1979-07-09 | 1981-03-10 | Pfizer Inc. | 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines |
EP0094586A3 (fr) * | 1982-05-13 | 1984-06-06 | Ono Pharmaceutical Co., Ltd. | Dérivés de glycérol, procédé pour leur préparation et compositions pharmaceutiques les contenant |
JPS5988447A (ja) * | 1982-11-11 | 1984-05-22 | Ono Pharmaceut Co Ltd | グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤 |
JPS60100544A (ja) * | 1983-11-08 | 1985-06-04 | Ono Pharmaceut Co Ltd | 新規なグリセリン誘導体,その製造方法及びその誘導体を含有する薬剤 |
JPS60104066A (ja) * | 1983-11-10 | 1985-06-08 | Ono Pharmaceut Co Ltd | グリセリン誘導体 |
JPS60105650A (ja) * | 1983-11-14 | 1985-06-11 | Ono Pharmaceut Co Ltd | グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤 |
JPS6164353A (ja) * | 1984-09-04 | 1986-04-02 | 川崎重工業株式会社 | 湿式ミルの運転方法 |
JPS6194657A (ja) * | 1984-10-16 | 1986-05-13 | 武田薬品工業株式会社 | バイアル用ゴム栓 |
US5545412A (en) * | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
CA1291036C (fr) * | 1986-04-23 | 1991-10-22 | Edwin I. Stoltz | Administration de medicaments par voie nasale |
US4751245A (en) * | 1986-06-25 | 1988-06-14 | E. R. Squibb & Sons, Inc. | Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same |
JPS63166237U (fr) * | 1987-04-16 | 1988-10-28 | ||
US5093198A (en) * | 1987-06-19 | 1992-03-03 | Temple University | Adjuvant-enhanced sustained release composition and method for making |
JPH0244750Y2 (fr) * | 1988-03-18 | 1990-11-28 | ||
US5176850A (en) * | 1988-07-21 | 1993-01-05 | Ciba-Geigy Corporation | Substituted glycerol compounds |
AU614636B2 (en) * | 1988-07-21 | 1991-09-05 | Ciba Specialty Chemicals Holding Inc. | Corrosion inhibition |
ZA899436B (en) * | 1988-12-12 | 1990-08-29 | Ciba Geigy | Piperidine derivatives |
JP2604268B2 (ja) * | 1990-04-09 | 1997-04-30 | 富士写真フイルム株式会社 | ペプチド誘導体両親媒性化合物、その中間体、ペプチド誘導体両親媒性化合物を用いたリポソームおよび薄膜 |
JPH0439597A (ja) * | 1990-06-01 | 1992-02-10 | Corona:Kk | 給湯装置の熱交換器 |
DE19521412A1 (de) * | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
DE19755268A1 (de) * | 1997-12-12 | 1999-06-17 | Merck Patent Gmbh | Benzamidinderivate |
GB0106041D0 (en) * | 2001-03-12 | 2001-05-02 | Cancer Res Ventures Ltd | Lipids and liposomes |
US7615604B2 (en) * | 2003-01-17 | 2009-11-10 | The United States Of America As Represented By The Secretary Of The Navy | Diols formed by ring-opening of epoxies |
US7622541B2 (en) * | 2003-01-17 | 2009-11-24 | The United States Of America As Represented By The Secretary Of The Navy | Polyurethane coating |
WO2009129385A1 (fr) * | 2008-04-16 | 2009-10-22 | Abbott Laboratories | Lipides cationiques et utilisations de ceux-ci |
WO2009129387A2 (fr) * | 2008-04-16 | 2009-10-22 | Abbott Laboratories | Lipides cationiques et utilisations associees |
WO2009129395A1 (fr) * | 2008-04-16 | 2009-10-22 | Abbott Laboratories | Lipides cationiques et utilisations de ceux-ci |
US8999960B2 (en) | 2008-10-08 | 2015-04-07 | Vascular Biogenics Ltd. | Oxidized thiophospholipid compounds and uses thereof |
EP2348866B1 (fr) | 2008-11-06 | 2015-01-07 | Vascular Biogenics Ltd. | Composés lipidiques oxydés et leurs utilisations |
CN102905763B (zh) | 2009-12-23 | 2015-06-17 | 诺华股份有限公司 | 脂质、脂质组合物和使用它们的方法 |
EP3169309B1 (fr) | 2014-07-16 | 2023-05-10 | Novartis AG | Procédé d'encapsulation d'un acide nucléique dans une nanoparticule lipidique hôte |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
ES2855299T3 (es) | 2014-11-26 | 2021-09-23 | Vascular Biogenics Ltd | Lípidos oxidados y tratamiento o prevención de la fibrosis |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1013603A (en) * | 1961-06-08 | 1965-12-15 | Sandoz Ltd | Level-dyeing process |
FR2102116A1 (fr) * | 1970-08-07 | 1972-04-07 | Pfizer | |
US3960958A (en) * | 1974-08-26 | 1976-06-01 | Pfizer Inc. | 3,4- AND 3,5-Dialkoxybenzylamines |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2738351A (en) * | 1952-08-02 | 1956-03-13 | Bristol Lab Inc | Substituted glycerol ethers |
US4025555A (en) * | 1976-07-23 | 1977-05-24 | Pfizer Inc. | Aromatic amidines as antiviral agents in animals |
-
1977
- 1977-08-18 US US05/825,535 patent/US4166132A/en not_active Expired - Lifetime
-
1978
- 1978-07-05 ZA ZA00783855A patent/ZA783855B/xx unknown
- 1978-07-18 IN IN525/DEL/78A patent/IN148386B/en unknown
- 1978-07-18 DK DK321478A patent/DK149022C/da not_active IP Right Cessation
- 1978-08-11 DE DE2835369A patent/DE2835369C2/de not_active Expired
- 1978-08-11 DE DE2857415A patent/DE2857415C2/de not_active Expired
- 1978-08-11 DE DE2857416A patent/DE2857416C2/de not_active Expired
- 1978-08-14 MX MX787311U patent/MX6091E/es unknown
- 1978-08-15 CH CH866378A patent/CH634544A5/fr not_active IP Right Cessation
- 1978-08-15 JP JP53099446A patent/JPS5829939B2/ja not_active Expired
- 1978-08-16 CA CA309,488A patent/CA1102354A/fr not_active Expired
- 1978-08-16 LU LU80114A patent/LU80114A1/fr unknown
- 1978-08-16 GB GB7833479A patent/GB2005248B/en not_active Expired
- 1978-08-16 IL IL55370A patent/IL55370A/xx unknown
- 1978-08-16 PT PT68426A patent/PT68426A/pt unknown
- 1978-08-16 EG EG514/78A patent/EG13438A/xx active
- 1978-08-16 GR GR57008A patent/GR73154B/el unknown
- 1978-08-16 SE SE7808701A patent/SE447823B/sv not_active IP Right Cessation
- 1978-08-17 AT AT0600278A patent/AT363922B/de not_active IP Right Cessation
- 1978-08-17 YU YU1974/78A patent/YU41115B/xx unknown
- 1978-08-17 IT IT26813/78A patent/IT1098280B/it active
- 1978-08-17 PL PL1978209092A patent/PL115777B1/pl unknown
- 1978-08-17 NO NO782791A patent/NO147300C/no unknown
- 1978-08-17 IE IE1658/78A patent/IE47151B1/en not_active IP Right Cessation
- 1978-08-17 PL PL1978219782A patent/PL116434B1/pl unknown
- 1978-08-17 HU HU78PI635A patent/HU177884B/hu unknown
- 1978-08-17 ES ES472659A patent/ES472659A1/es not_active Expired
- 1978-08-17 PH PH21505A patent/PH16469A/en unknown
- 1978-08-17 BE BE189922A patent/BE869793A/fr not_active IP Right Cessation
- 1978-08-17 FI FI782518A patent/FI67687C/fi not_active IP Right Cessation
- 1978-08-17 PL PL1978219781A patent/PL116119B1/pl unknown
- 1978-08-17 HU HU78802928A patent/HU181238B/hu unknown
- 1978-08-17 FR FR7824017A patent/FR2421871A1/fr active Granted
- 1978-08-17 SU SU782650899A patent/SU893128A3/ru active
- 1978-08-17 AU AU39021/78A patent/AU503079B1/en not_active Expired
- 1978-08-17 NZ NZ188174A patent/NZ188174A/en unknown
- 1978-08-17 CS CS785378A patent/CS208155B2/cs unknown
- 1978-08-18 DD DD78207370A patent/DD143902A5/de unknown
- 1978-08-18 DD DD78218816A patent/DD148951A5/de unknown
- 1978-08-18 NL NLAANVRAGE7808565,A patent/NL176670C/xx not_active IP Right Cessation
- 1978-08-18 AR AR273345A patent/AR219543A1/es active
-
1979
- 1979-03-06 FR FR7905721A patent/FR2414038A1/fr active Granted
- 1979-04-16 ES ES479616A patent/ES479616A1/es not_active Expired
- 1979-04-16 ES ES479615A patent/ES479615A1/es not_active Expired
- 1979-06-21 AR AR276987A patent/AR218733A1/es active
- 1979-08-17 SU SU792797789A patent/SU906363A3/ru active
- 1979-08-31 SU SU792807156A patent/SU850005A3/ru active
-
1981
- 1981-09-30 NO NO813325A patent/NO147670C/no unknown
- 1981-09-30 NO NO81813324A patent/NO154344C/no unknown
-
1982
- 1982-02-19 JP JP57025823A patent/JPS5924144B2/ja not_active Expired
- 1982-02-19 JP JP57025822A patent/JPS5929582B2/ja not_active Expired
- 1982-09-15 PH PH27875A patent/PH18067A/en unknown
- 1982-09-15 PH PH27876A patent/PH17789A/en unknown
- 1982-09-21 PH PH27896A patent/PH18111A/en unknown
- 1982-11-24 YU YU2629/82A patent/YU41276B/xx unknown
- 1982-11-24 YU YU2630/82A patent/YU41277B/xx unknown
-
1984
- 1984-04-03 SE SE8401849A patent/SE463456B/sv not_active IP Right Cessation
- 1984-04-03 SE SE8401850A patent/SE8401850L/xx not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1013603A (en) * | 1961-06-08 | 1965-12-15 | Sandoz Ltd | Level-dyeing process |
FR2102116A1 (fr) * | 1970-08-07 | 1972-04-07 | Pfizer | |
US3960958A (en) * | 1974-08-26 | 1976-06-01 | Pfizer Inc. | 3,4- AND 3,5-Dialkoxybenzylamines |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2421871A1 (fr) | Nouveaux derives d'amines et amidines de glycerols et propanediols et medicament les contenant | |
FR2427333A1 (fr) | Nouveaux aminothiazoles et composition pharmaceutique les contenant | |
FR2370722A1 (fr) | Nouveaux benzamides trans-n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant | |
RU94016183A (ru) | Производные пиперазина | |
FR2450832A1 (fr) | Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant | |
FR2430403A1 (fr) | Nouvelles 15-deoxy-16-hydroxy-prostaglandines, leur procede de production et medicament les contenant | |
FR2404625A1 (fr) | Nouveaux 4-aminocyclohexanols et composition pharmaceutique les contenant | |
FR2432519A1 (fr) | Nouveaux derives de purine et medicament les contenant | |
FR2424908A1 (fr) | Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant | |
FR2424917A1 (fr) | Nouvelles 4-quinolinylaminobenzoyl-piperidines, leur procede de production et medicament les contenant | |
DE68912022D1 (de) | Reizvermeidende und desensibilisierende Zusammensetzungen und Verfahren zu deren Anwendung. | |
FR2426039A1 (fr) | Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant | |
FR2412535A1 (fr) | Ethers imidazolylvinyliques et produits fongicides qui en contiennent | |
FR2393577A1 (fr) | Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse | |
FR2450820A1 (fr) | Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation | |
FR2446819A1 (fr) | Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant | |
FR2402666A1 (fr) | 5-iminodaunomycine et medicament la contenant | |
FR2422405A1 (fr) | Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
EA200400707A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
FR2361361A1 (fr) | Nouveaux derives du cyclopentane et medicaments contenant ces substances | |
BE885393A (fr) | Nouveaux amino-2 benzoyl-3 phenylacetamides et leurs homologues cycliques utiles comme medicaments et compositions therapeutiques et formes pharmaceutiques les contenant | |
FR2401141A1 (fr) | Nouveaux derives halogenes de prostaglandines et medicaments les contenant | |
FR2424277A1 (fr) | 8b-ethyl-(ou methyl)-4,5a-epoxymorphinane-6-ones, leur procede de production et medicaments les contenant | |
FR2401143A1 (fr) | Nouvelles n-cyano-n'-(2-((4-methyl-5-imidazolyl) - methylthio)ethyl) - n''-alcynylguanidines, leur procede de preparation et medicament les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |